A Phase 2 Open-Label, Multicenter Study to Evaluate Efficacy and Safety of ZN-c3 in Adult Women with Recurrent or Persistent Uterine Serous Carcinoma [ZN-c3-004]
- Richardson, Gary (Primary Chief Investigator (PCI))
- Lai, Li Hoon (Project Manager)
Project: Research